Ensign Peak Advisors
TECX

Ensign Peak Advisors’s Tectonic Therapeutic TECX Stock Holding History

Ensign Peak Advisors’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-410
Closed -$86K – 1764
2020
Q2 		$86K Hold
410
– – ﹤0.01% 1639
2020
Q1 		$77K Buy
+410
New +$96.6K ﹤0.01% 1587

Other funds holding TECX

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Ensign Peak Advisors's TECX Position: Q3 2020 in Review

Ensign Peak Advisors sold out of Tectonic Therapeutic (TECX) in Q3 2020, closing a stake of 410 shares — an estimated $86K sold.

Ensign Peak Advisors first reported a position in TECX in Q1 2020 and held it in 2 quarters. The position peaked at $86K in Q2 2020. 101 funds tracked by Wall St. Rank hold TECX as of Q3 2020.

  • Ensign Peak Advisors reported no remaining Tectonic Therapeutic position as of Q3 2020 after selling out during the quarter.
  • Ensign Peak Advisors sold 410 Tectonic Therapeutic shares in Q3 2020, an estimated $86K.
  • Ensign Peak Advisors first reported a position in Tectonic Therapeutic in Q1 2020 and held it in 2 quarters.
  • Ensign Peak Advisors's Tectonic Therapeutic position peaked at $86K in Q2 2020.
  • 101 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2020.

Based on Ensign Peak Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.